Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWalker Crips Regulatory News (WCW)

  • This share is currently suspended. It was suspended at a price of 13.50
  • There is currently no data for WCW

Working Capital Loan Drawdown Facility

31 Jul 2025 17:45

RNS Number : 4922T
Walker Crips Group plc
31 July 2025
 

 

 

Walker Crips Group plc

 

("Walker Crips" or the "Company")

 

Working Capital Loan Drawdown Facility Secured

 

Walker Crips announces that it has secured a £5m Working Capital Loan Drawdown Facility ('Facility') from its largest shareholder, Phillip Brokerage Pte Ltd ('PhillipCapital'). The Facility provides the Company with necessary funding to support its future plans and reinforce the Company's financial stability.

 

The Facility is for a maximum of £5m, with a fixed term of 2 years from 31 July 2025. Interest will only be charged on the amount drawn down at 9.07% per annum, and there is a one-off Facility Fee of 1% (£50,000). Other than the one-off Facility Fee, there will be no other costs if no drawdown has been made. The Facility can be repaid at any time without penalty.

 

If any amount of the Facility (including accrued but unpaid interest) remains drawn down six months from the date of the agreement, the Company will be required to initiate a rights issue for the purpose of repayment of the Facility. If the Facility is undrawn or is drawn and repaid in full (including accrued interest) as at 31 January 2026 then there will be no requirement for the Company to initiate a rights issue. The Company intends to repay any drawn amounts ahead of 31 January 2026.

 

The Company requires this funding in light of an especially challenging last financial year, as announced in the Company's full year results to 31 March 2025. As a result of a number of historic issues, there has been a requirement both to fund substantial investment in legal and consulting services, as well as the recruitment of additional Compliance personnel. The Facility has therefore been put in place to reinforce the Company's financial position following significant expenditure, and will be utilised to support the Company's growth plans in the near term.

 

Jo Welman, Chairman, commented: "We have secured a £5m loan facility from PhillipCapital, one of our major shareholders, to provide the necessary funding to support our future plans and reinforce the Group's financial stability. The availability of this loan is instrumental, without it, the Group would lack the capacity to implement essential changes and invest in the growth strategies required to move our business forward. We continue to actively explore a broad range of strategic options aimed at further strengthening our balance sheet and positioning the Group for long-term success."

 

Additional information

 

Phillip Brokerage PTE Ltd and its connected parties hold 12,359,803 shares in the Company, equivalent to 29.03% per cent. of the Company's issued share capital. As a result of its shareholding in the Company, Phillip Brokerage PTE Ltd is defined as a related party under the UK Listing Rules ("UKLRs") and the provision of the Facility constitutes a related party transaction under paragraph 8.2.1R of the UKLRs.

 

The Board (comprised for these purposes of all directors with the exception of Hua Min Lim and Linus Lim) confirms its view that the provision of the Facility is fair and reasonable as far as the shareholders of Walker Crips are concerned and that the Board has been so advised by Singer Capital Markets in its role as the Company's sponsor in connection with the Facility.

 

 

For further information, please contact:

 

Walker Crips Group plc

Craig Harrison, Media Relations

Tel: +44 (0)20 3100 8000

Singer Capital Markets

Charles Leigh-Pemberton / Asha Chotai

Tel: +44 (0)20 7496 3000

 

 

Further information on Walker Crips Group is available on the Company's website: www.walkercrips.co.uk

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBLGDRIDXDGUB
Date   Source Headline
25th Nov 20257:00 amRNSForm 8.3 - Walker Crips Group PLC
24th Nov 20257:47 amRNSDisclosure Table
24th Nov 20257:00 amRNSRecommended Cash Offer for Walker Crips Group PLC
24th Nov 20257:00 amRNSWorking Capital Loan Extension & Trading Update
29th Sep 20255:04 pmRNSResult of AGM
3rd Sep 20255:45 pmRNSDirectorate Change
14th Aug 20255:30 pmRNSDirectorate Change
31st Jul 20255:45 pmRNSWorking Capital Loan Drawdown Facility
31st Jul 20255:45 pmRNSFinal Results
9th Jul 20251:15 pmRNSBoard and Management Changes
28th Apr 20255:45 pmRNSAppointment of Non-Executive Director
7th Apr 202510:36 amRNSDirector Declaration
31st Mar 20255:45 pmRNSAppointment of Non-Executive Chairman
12th Feb 20254:32 pmRNSDirector Declaration
6th Feb 20255:45 pmRNSDirectorate Changes
27th Dec 20249:45 amRNSResults for the six months ended 30 September 2024
27th Nov 20247:30 amRNSDirector/PDMR Shareholding
27th Sep 202412:00 pmRNSResult of AGM
31st Jul 20241:00 pmRNSFinal results for the year ended 31 March 2024
14th Jun 202410:01 amRNSResignation of Non-executive Director
28th Dec 202312:15 pmRNSResults for the six months ended 30 September 2023
27th Sep 20232:07 pmRNSResult of AGM
31st Jul 20236:25 pmRNSFinal results for the year ended 31 March 2023
23rd Dec 202210:00 amRNSHalf-year Report
11th Oct 20225:19 pmRNSDirector/PDMR Shareholding
29th Sep 20221:37 pmRNSResult of AGM
29th Jul 20223:01 pmRNSFinal Results
9th Jun 20223:28 pmRNSHolding(s) in Company
26th Apr 20222:17 pmRNSDirector/PDMR Shareholding
29th Mar 20223:25 pmRNSDirector/PDMR Shareholding
16th Dec 20217:00 amRNSHalf-year Report
28th Sep 20211:12 pmRNSResult of AGM
16th Sep 20219:06 amRNSSecond Price Monitoring Extn
16th Sep 20219:00 amRNSPrice Monitoring Extension
20th Aug 20213:40 pmRNSFinal Results
28th Jan 20215:39 pmRNSDirector/PDMR Shareholding
27th Jan 20217:00 amRNSDirector/PDMR Shareholding
22nd Jan 202112:03 pmRNSDirector/PDMR Shareholding
22nd Dec 20203:00 pmRNSExternal Auditor Appointment
27th Nov 20209:34 amRNSHalf-year Report - Replacement
27th Nov 20207:00 amRNSHalf-year Report
28th Oct 20209:24 amRNSDirector/PDMR Shareholding
2nd Oct 20203:55 pmRNSDirector/PDMR Shareholding
28th Sep 20207:00 amRNSDirector/PDMR Shareholding
18th Sep 20205:57 pmRNSDirector/PDMR Shareholding - Replacement
18th Sep 20204:48 pmRNSDirector/PDMR Shareholding
11th Sep 202010:01 amRNSDirector/PDMR Shareholding
9th Sep 202012:30 pmRNSResult of AGM
19th Aug 202012:25 pmRNSDirector/PDMR Shareholding
4th Aug 20202:59 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.